Provided by Tiger Trade Technology Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

2.36
+0.09003.96%
Post-market: 2.360.00000.00%16:15 EDT
Volume:16.98K
Turnover:39.54K
Market Cap:7.12M
PE:-0.28
High:2.40
Open:2.33
Low:2.27
Close:2.27
52wk High:24.90
52wk Low:1.52
Shares:3.02M
Float Shares:2.79M
Volume Ratio:0.22
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.4407
EPS(LYR):-20.0407
ROE:-307.69%
ROA:-76.20%
PB:1.29
PE(LYR):-0.12

Loading ...

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(K) Submission

THOMSON REUTERS
·
Jun 02

Intelligent Bio Solutions Q3 Basic EPS USD -1.8

THOMSON REUTERS
·
May 13

Intelligent Bio Solutions Q3 EPS $(1.80) Up From $(4.40) YoY, Sales $1.060M Up From $728.867K YoY

Benzinga Earnings
·
May 13

Intelligent Bio Solutions Q3 FY26 net loss widens to $2.87 million; revenue rises 46% to $1.06 million

Reuters
·
May 13

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-Over-Year

THOMSON REUTERS
·
May 13

Press Release: Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Dow Jones
·
May 13

Intelligent Bio Solutions publishes investor presentation on fingerprint sweat drug screening system

Reuters
·
Apr 21

Intelligent Bio Solutions announces launch of validation study for IFDSS

TIPRANKS
·
Apr 20

BUZZ-Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing

Reuters
·
Apr 17

Intelligent Bio Solutions advances FDA 510(k) submission after penetration test finds no major flaws

Reuters
·
Apr 17

Intelligent Bio Solutions Advances Upcoming FDA 510(K) Submission, Successfully Completes Penetration Testing With No Major Vulnerabilities Identified

THOMSON REUTERS
·
Apr 17

BRIEF-Intelligent Bio Solutions Completes Clinical Cut-Off Study

Reuters
·
Apr 02

Intelligent Bio Solutions completes FDA 510(k) cut-off study for codeine fingerprint test

Reuters
·
Apr 02

Intelligent Bio Solutions Inc: Expects to Complete Method Comparison and Usability Study by End of June 2026

THOMSON REUTERS
·
Apr 02

Intelligent Bio Solutions Inc: NOW Initiated Second Phase of Its Clinical Study Program

THOMSON REUTERS
·
Apr 02

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(K) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

THOMSON REUTERS
·
Apr 02

Intelligent Bio Solutions receives European Patent EP3752831; European patent count rises to eight

Reuters
·
Mar 26

Intelligent Bio Solutions grants CEO and CFO 9,150 time-vesting restricted shares each

Reuters
·
Mar 24